Amid Flu Epidemic a Focus on Vaccine Innovation

Article

Pharmaceutical Executive

 

Recent Videos
James Foster
John Arena
James Foster
Navigating an Uncertain Regulatory Landscape
James Foster
Related Content
Epitopea Strikes Research Collaboration with Merck, Appoints Klaus Edvardsen as Chief Medical Officer

Epitopea Strikes Research Collaboration with Merck, Appoints Klaus Edvardsen as Chief Medical Officer

Don Tracy, Associate Editor
February 19th 2025
Article

Under terms of the deal, Epitopea and Merck will work to identify Cryptigen tumor-specific antigens through Epitopea’s CryptoMap platform.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement Policies, Cuts to Indirect Research Costs To Impact T1D & more

Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement Policies, Cuts to Indirect Research Costs To Impact T1D & more

Miranda Schmalfuhs
February 19th 2025
Article

The latest news for pharma industry insiders.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya

FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya

Don Tracy, Associate Editor
February 18th 2025
Article

Vimkunya is the first FDA-approved vaccine for chikungunya in patients over 12 years of age.

Pharma Pulse 2/18/25: HCP and Patient Influence on the CGT Approval Process, Enhancing Care for ALZ Patients & more

Pharma Pulse 2/18/25: HCP and Patient Influence on the CGT Approval Process, Enhancing Care for ALZ Patients & more

Miranda Schmalfuhs
February 18th 2025
Article

The latest news for pharma industry insiders.